Sign in

You're signed outSign in or to get full access.

Eitan Ajchenbaum

Director at Pluri
Board

About Eitan Ajchenbaum

Eitan Ajchenbaum (age 63) is an independent director of Pluri Inc., appointed on September 10, 2025. He serves as Chair of the Audit Committee (designated an audit committee financial expert) and is the sole member of the Investment Committee; the Board determined he is independent under SEC and Nasdaq rules and used his appointment to regain Nasdaq audit committee compliance on September 11, 2025. He is a CPA (Israel) with 30+ years in senior finance roles; he holds a B.A. in Accounting and Economics from Tel-Aviv University and has expertise in U.S. GAAP/IFRS, risk management, internal controls, and corporate governance .

Past Roles

OrganizationRoleTenureCommittees/Impact
Berkshire Hathaway GuardChief Financial Officer and Treasurer; previously Chief Risk Officer; board member in most Guard group companies2011–Apr 2024; board since 2007Led finance, accounting, corporate legal, investments, internal audit, and risk management .
Bezeq International Ltd. (BZQIY.TA)Chief Financial Officern/dSenior finance leadership .
Direct Insurance Ltd. (DRIN.TA)Executive Vice Presidentn/dSenior operating/finance role .
Analyst Investment Company Ltd. (ANLT.TA)Finance & Organization Managern/dFinance/operations leadership .
Kesselman & Kesselman (PwC Israel)Auditor (early career)n/dFoundational audit experience .

External Roles

OrganizationRoleTenureNotes
WeSure Global Tech Ltd. (WESR.TA)Chief Financial Officer & Deputy Chief Executive OfficerSince June 2025Public holding company in financial/insurance arenas (Tel-Aviv Stock Exchange) .

Board Governance

ItemDetails
IndependenceBoard determined Ajchenbaum is independent under SEC and Nasdaq rules .
Audit CommitteeChair; designated audit committee financial expert; appointment on Sept 10, 2025 restored Nasdaq audit committee compliance on Sept 11, 2025 .
Investment CommitteeSole member (appointed Sept 10, 2025); responsibilities include managing investment portfolio, investment guidelines/hedging, FX risk, adviser oversight .
Audit Committee scopeExternal auditor oversight; financial reporting review; internal controls; disclosure procedures; cybersecurity risk oversight .
Committee activity levelsAudit Committee held seven meetings and acted by written consent twice in fiscal 2025 .
Board meetings (context)In fiscal 2024, Board held nine meetings; all then-directors met 75%+ attendance; Ajchenbaum was not yet on the Board .

Fixed Compensation

Not disclosed for Ajchenbaum as of the 2025 proxy/10-K period (he joined after the fiscal 2024 director compensation disclosure). The Company compensates non-employee directors with a mix of cash fees and share-based awards; 2024 director compensation (excluding Ajchenbaum) included cash fees and RSU grants, with equity plan administration under the 2016 and 2019 plans .

Performance Compensation

FeatureDetails
Equity plan(s)Directors may receive RSUs under the 2016 Equity Compensation Plan and 2019 Plan; awards and administration at Compensation Committee/Board discretion .
ClawbackCompensation Committee administers the Company’s clawback policy .
Vesting/acceleration (directors)For directors, 100% vesting acceleration if not re-nominated or not re-elected; up to 50% acceleration on voluntary resignation (subject to Board approval); 100% acceleration on change in control .

Other Directorships & Interlocks

CategoryDisclosure
Current public company directorshipsNone disclosed for Ajchenbaum .
Prior public company boardsBoard member in most Berkshire Hathaway Guard group companies (subsidiaries) since 2007 .
Potential interlocksNone disclosed; Board confirms independence .

Expertise & Qualifications

  • CPA (Israel); B.A. in Accounting & Economics, Tel‑Aviv University .
  • Financial reporting under U.S. GAAP and IFRS; risk management and internal controls; corporate governance .
  • Designated Audit Committee financial expert .
  • Deep operating experience in insurance, telecom, and investment management .

Equity Ownership

As ofFilingReported HoldingsNotes
Sept 10, 2025 (event); signed Sept 22, 2025Form 30 shares; “No securities are beneficially owned.”Initial statement upon joining Board; subsequent grants/holdings not disclosed in available filings .

Insider Filings

Date (Event/Filed)FormSummaryPost-Filing Holdings
09/10/2025 (event); 09/22/2025 (filed)Form 3Initial statement of beneficial ownership upon becoming Director0; “No securities are beneficially owned.” .

Governance Assessment

  • Positives

    • The Board appointed Ajchenbaum as Audit Committee Chair and audit committee financial expert, restoring Nasdaq audit committee compliance one day post‑appointment; this is a strong signal on governance responsiveness and financial oversight depth .
    • Concentrated risk oversight remit includes cybersecurity within Audit and investment/FX oversight within the Investment Committee, aligning with his finance/risk background .
    • Board confirms independence; no related‑party transactions involving Ajchenbaum disclosed in Item 13; existing related‑party activity in 2025 involved another director (Weinstein) and was separately disclosed .
  • Watch items / potential red flags

    • Committee workload concentration: Ajchenbaum chairs Audit and is sole member of the Investment Committee; while efficient, this centralization elevates key‑person risk on risk, audit, and treasury oversight. Consider monitoring committee resourcing and succession plans .
    • Perception risk: Ajchenbaum began his career at Kesselman & Kesselman (PwC Israel), which is the Company’s current independent auditor—Board maintains his independence, but investors may monitor for any auditor oversight sensitivities; no conflicts are disclosed .
  • Context on compensation governance

    • Compensation Committee is independent and administers equity plans and the clawback policy; historically has used independent consultants (e.g., Deloitte Israel) to benchmark compensation—an indicator of structured pay governance .

Attendance: Fiscal 2025 committee attendance for Ajchenbaum not individually disclosed; Audit Committee met seven times in 2025. Fiscal 2024 Board attendance was 75%+ for all then-directors (preceded Ajchenbaum’s tenure) .